Genizon Bioscience licenses Crohn's disease genemap to Genentech

10-Aug-2006

Genizon BioSciences announced a license and collaboration agreement with Genentech, Inc. Genizon grants Genentech an exclusive license to Genizon's GeneMap of disease-associated genes generated from a whole genome association study of Crohn's disease patients from the Quebec Founder Population.

Under the terms of the agreement, Genizon will receive an upfront payment, research funding and milestone payments for each therapeutic product that may emerge from the collaboration. Financial terms were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances